APP and Alzheimer disease: These GM1-Aβ complexes, identified in early-stage AD patient brains, are linked to the presence of Aβ oligomers in the cerebrospinal fluid (CSF), underlining the significant impact of sphingolipids on APP processing, Aβ generation, and amyloid accumulation (Hong et al., 2014).